Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia

go back to reference Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51(2):189–199PubMed Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51(2):189–199PubMed

go back to reference Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405CrossRef Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405CrossRef

go back to reference Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89(6):2079–2088PubMed Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89(6):2079–2088PubMed

go back to reference Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SMM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120(12):2454–2465PubMedPubMedCentral Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SMM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120(12):2454–2465PubMedPubMedCentral

go back to reference Paganin M, Buldini B, Germano G, Seganfreddo E, Meglio A, Magrin E, Grillo F, Pigazzi M, Rizzari C, Cazzaniga G, Khiabanian H, Palomero T, Rabadan R, Ferrando AA, Basso G (2016) A case of T-cell acute lymphoblastic leukemia relapsed as myeloid acute leukemia. Pediatr Blood Cancer 63(9):1660–1663PubMed Paganin M, Buldini B, Germano G, Seganfreddo E, Meglio A, Magrin E, Grillo F, Pigazzi M, Rizzari C, Cazzaniga G, Khiabanian H, Palomero T, Rabadan R, Ferrando AA, Basso G (2016) A case of T-cell acute lymphoblastic leukemia relapsed as myeloid acute leukemia. Pediatr Blood Cancer 63(9):1660–1663PubMed

go back to reference Dorantes-Acosta E, Pelayo R (2012) Lineage switching in acute leukemias: a consequence of stem cell plasticity? Bone Marrow Res 2012:406796PubMedPubMedCentral Dorantes-Acosta E, Pelayo R (2012) Lineage switching in acute leukemias: a consequence of stem cell plasticity? Bone Marrow Res 2012:406796PubMedPubMedCentral

go back to reference Hijiya N, Ness KK, Ribeiro RC, Hudson MM (2009) Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer 115(1):23–35PubMedPubMedCentral Hijiya N, Ness KK, Ribeiro RC, Hudson MM (2009) Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer 115(1):23–35PubMedPubMedCentral

go back to reference Gagnon GA, Childs CC, LeMaistre A, Keating M, Cork A, Trujillo JM, Nellis K, Freireich E, Stass SA (1989) Molecular heterogeneity in acute leukemia lineage switch. Blood 74(6):2088–2095PubMed Gagnon GA, Childs CC, LeMaistre A, Keating M, Cork A, Trujillo JM, Nellis K, Freireich E, Stass SA (1989) Molecular heterogeneity in acute leukemia lineage switch. Blood 74(6):2088–2095PubMed

go back to reference Stass SA, Mirro J Jr (1986) Lineage heterogeneity in acute leukaemia: acute mixed-lineage leukaemia and lineage switch. Clin Haematol 15(3):811–827PubMed Stass SA, Mirro J Jr (1986) Lineage heterogeneity in acute leukaemia: acute mixed-lineage leukaemia and lineage switch. Clin Haematol 15(3):811–827PubMed

go back to reference Zhang Y, Gao S, Xia J, Liu F (2018) Hematopoietic hierarchy - an updated roadmap. Trends Cell Biol 28(12):976–986PubMed Zhang Y, Gao S, Xia J, Liu F (2018) Hematopoietic hierarchy - an updated roadmap. Trends Cell Biol 28(12):976–986PubMed

go back to reference Nutt SL, Heavey B, Rolink AG, Busslinger M (1999) Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401(6753):556–562PubMed Nutt SL, Heavey B, Rolink AG, Busslinger M (1999) Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401(6753):556–562PubMed

go back to reference Pongubala JM, Northrup DL, Lancki DW et al (2008) Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat Immunol 9(2):203–215PubMed Pongubala JM, Northrup DL, Lancki DW et al (2008) Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat Immunol 9(2):203–215PubMed

go back to reference Heavey B, Charalambous C, Cobaleda C, Busslinger M (2003) Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors. EMBO J 22(15):3887–3897PubMedPubMedCentral Heavey B, Charalambous C, Cobaleda C, Busslinger M (2003) Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors. EMBO J 22(15):3887–3897PubMedPubMedCentral

go back to reference Iwasaki H, Mizuno S, Arinobu Y, Ozawa H, Mori Y, Shigematsu H, Takatsu K, Tenen DG, Akashi K (2006) The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev 20(21):3010–3021PubMedPubMedCentral Iwasaki H, Mizuno S, Arinobu Y, Ozawa H, Mori Y, Shigematsu H, Takatsu K, Tenen DG, Akashi K (2006) The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev 20(21):3010–3021PubMedPubMedCentral

go back to reference Im AP, Sehgal AR, Carroll MP, Smith BD, Tefferi A, Johnson DE, Boyiadzis M (2014) DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Leukemia 28(9):1774–1783PubMedPubMedCentral Im AP, Sehgal AR, Carroll MP, Smith BD, Tefferi A, Johnson DE, Boyiadzis M (2014) DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies. Leukemia 28(9):1774–1783PubMedPubMedCentral

go back to reference Koya J, Kataoka K, Sato T, Bando M, Kato Y, Tsuruta-Kishino T, Kobayashi H, Narukawa K, Miyoshi H, Shirahige K, Kurokawa M (2016) DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nat Commun 7:10924PubMedPubMedCentral Koya J, Kataoka K, Sato T, Bando M, Kato Y, Tsuruta-Kishino T, Kobayashi H, Narukawa K, Miyoshi H, Shirahige K, Kurokawa M (2016) DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nat Commun 7:10924PubMedPubMedCentral

go back to reference Chan SM, Majeti R (2013) Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia. Int J Hematol 98(6):648–657PubMedPubMedCentral Chan SM, Majeti R (2013) Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia. Int J Hematol 98(6):648–657PubMedPubMedCentral

go back to reference Burgos S, Montalban-Bravo G, Fuente L, Jabbour EJ, Kanagal-Shamanna R, Soltysiak KA, Garcia-Manero G, Mela-Osorio MJ (2019) Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: a case report. Medicine (Baltimore) 98(1):e14011 Burgos S, Montalban-Bravo G, Fuente L, Jabbour EJ, Kanagal-Shamanna R, Soltysiak KA, Garcia-Manero G, Mela-Osorio MJ (2019) Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: a case report. Medicine (Baltimore) 98(1):e14011

go back to reference Guo ZP, Tan YH, Li JL, Xu ZF, Chen XH, Xu LR (2018) Acute pro-B-cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: a case report with literature review. Oncol Lett 15(6):9745–9750PubMedPubMedCentral Guo ZP, Tan YH, Li JL, Xu ZF, Chen XH, Xu LR (2018) Acute pro-B-cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: a case report with literature review. Oncol Lett 15(6):9745–9750PubMedPubMedCentral

go back to reference Su IH, Basavaraj A, Krutchinsky AN, Hobert O, Ullrich A, Chait BT, Tarakhovsky A (2003) Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol 4(2):124–131PubMed Su IH, Basavaraj A, Krutchinsky AN, Hobert O, Ullrich A, Chait BT, Tarakhovsky A (2003) Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol 4(2):124–131PubMed

go back to reference Rao RC, Dou Y (2015) Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat Rev Cancer 15(6):334–346PubMedPubMedCentral Rao RC, Dou Y (2015) Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat Rev Cancer 15(6):334–346PubMedPubMedCentral

go back to reference Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJL, Leszl A, Litvinko N, Nigro LL, Morimoto A, Perot C, Pieters R, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Zwaan CM, van den Heuvel-Eibrink MM (2009) Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 114(12):2489–2496PubMedPubMedCentral Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJL, Leszl A, Litvinko N, Nigro LL, Morimoto A, Perot C, Pieters R, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Zwaan CM, van den Heuvel-Eibrink MM (2009) Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 114(12):2489–2496PubMedPubMedCentral

go back to reference Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM (2004) Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program 2004:118–145 Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM (2004) Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program 2004:118–145

go back to reference Pendleton M, Lindsey RH Jr, Felix CA, Grimwade D, Osheroff N (2014) Topoisomerase II and leukemia. Ann N Y Acad Sci 1310:98–110PubMedPubMedCentral Pendleton M, Lindsey RH Jr, Felix CA, Grimwade D, Osheroff N (2014) Topoisomerase II and leukemia. Ann N Y Acad Sci 1310:98–110PubMedPubMedCentral

go back to reference Liu H, Cheng EH, Hsieh JJ (2009) MLL fusions: pathways to leukemia. Cancer Biol Ther 8(13):1204–1211PubMedPubMedCentral Liu H, Cheng EH, Hsieh JJ (2009) MLL fusions: pathways to leukemia. Cancer Biol Ther 8(13):1204–1211PubMedPubMedCentral

go back to reference Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M, Pombo de Oliveira M, Renneville A, Villarese P, Macintyre E, Cavé H, Clappier E, Mass-Malo K, Zuna J, Trka J, de Braekeleer E, de Braekeleer M, Oh SH, Tsaur G, Fechina L, van der Velden VHJ, van Dongen JJM, Delabesse E, Binato R, Silva MLM, Kustanovich A, Aleinikova O, Harris MH, Lund-Aho T, Juvonen V, Heidenreich O, Vormoor J, Choi WWL, Jarosova M, Kolenova A, Bueno C, Menendez P, Wehner S, Eckert C, Talmant P, Tondeur S, Lippert E, Launay E, Henry C, Ballerini P, Lapillone H, Callanan MB, Cayuela JM, Herbaux C, Cazzaniga G, Kakadiya PM, Bohlander S, Ahlmann M, Choi JR, Gameiro P, Lee DS, Krauter J, Cornillet-Lefebvre P, te Kronnie G, Schäfer BW, Kubetzko S, Alonso CN, zur Stadt U, Sutton R, Venn NC, Izraeli S, Trakhtenbrot L, Madsen HO, Archer P, Hancock J, Cerveira N, Teixeira MR, Lo Nigro L, Möricke A, Stanulla M, Schrappe M, Sedék L, Szczepański T, Zwaan CM, Coenen EA, van den Heuvel-Eibrink MM, Strehl S, Dworzak M, Panzer-Grümayer R, Dingermann T, Klingebiel T, Marschalek R (2013) The MLL recombinome of acute leukemias in 2013. Leukemia 27(11):2165–2176PubMedPubMedCentral Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M, Pombo de Oliveira M, Renneville A, Villarese P, Macintyre E, Cavé H, Clappier E, Mass-Malo K, Zuna J, Trka J, de Braekeleer E, de Braekeleer M, Oh SH, Tsaur G, Fechina L, van der Velden VHJ, van Dongen JJM, Delabesse E, Binato R, Silva MLM, Kustanovich A, Aleinikova O, Harris MH, Lund-Aho T, Juvonen V, Heidenreich O, Vormoor J, Choi WWL, Jarosova M, Kolenova A, Bueno C, Menendez P, Wehner S, Eckert C, Talmant P, Tondeur S, Lippert E, Launay E, Henry C, Ballerini P, Lapillone H, Callanan MB, Cayuela JM, Herbaux C, Cazzaniga G, Kakadiya PM, Bohlander S, Ahlmann M, Choi JR, Gameiro P, Lee DS, Krauter J, Cornillet-Lefebvre P, te Kronnie G, Schäfer BW, Kubetzko S, Alonso CN, zur Stadt U, Sutton R, Venn NC, Izraeli S, Trakhtenbrot L, Madsen HO, Archer P, Hancock J, Cerveira N, Teixeira MR, Lo Nigro L, Möricke A, Stanulla M, Schrappe M, Sedék L, Szczepański T, Zwaan CM, Coenen EA, van den Heuvel-Eibrink MM, Strehl S, Dworzak M, Panzer-Grümayer R, Dingermann T, Klingebiel T, Marschalek R (2013) The MLL recombinome of acute leukemias in 2013. Leukemia 27(11):2165–2176PubMedPubMedCentral

go back to reference Lin S, Luo RT, Shrestha M, Thirman MJ, Mulloy JC (2017) The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment. Blood 130(7):903–907PubMedPubMedCentral Lin S, Luo RT, Shrestha M, Thirman MJ, Mulloy JC (2017) The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment. Blood 130(7):903–907PubMedPubMedCentral

go back to reference Trikalinos NA, Soupir CP, Dey BR (2009) Lineage switch of acute lymphocyctic leukaemia with t(4;11)(q21;q23) into acute myeloid leukaemia in an adult patient after allogeneic stem cell transplantation. Br J Haematol 145(2):262–264PubMed Trikalinos NA, Soupir CP, Dey BR (2009) Lineage switch of acute lymphocyctic leukaemia with t(4;11)(q21;q23) into acute myeloid leukaemia in an adult patient after allogeneic stem cell transplantation. Br J Haematol 145(2):262–264PubMed

go back to reference Stasik C, Ganguly S, Cunningham MT, Hagemeister S, Persons DL (2006) Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia. Cancer Genet Cytogenet 168(2):146–149PubMed Stasik C, Ganguly S, Cunningham MT, Hagemeister S, Persons DL (2006) Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia. Cancer Genet Cytogenet 168(2):146–149PubMed

go back to reference Goel R, Kumar R, Bakhshi S (2007) Transformation of childhood MDS-refractory anemia to acute lymphoblastic leukemia. J Pediatr Hematol Oncol 29(10):725–727PubMed Goel R, Kumar R, Bakhshi S (2007) Transformation of childhood MDS-refractory anemia to acute lymphoblastic leukemia. J Pediatr Hematol Oncol 29(10):725–727PubMed

go back to reference Gupta V, Bhatia B (2010) Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia in a child. Indian J Hematol Blood Transfus 26(3):111–113PubMedPubMedCentral Gupta V, Bhatia B (2010) Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia in a child. Indian J Hematol Blood Transfus 26(3):111–113PubMedPubMedCentral

go back to reference Guillen M, Madero L, Parra L et al (2013) Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: 2 new cases. An Pediatr (Barc) 78(6):393–397 Guillen M, Madero L, Parra L et al (2013) Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: 2 new cases. An Pediatr (Barc) 78(6):393–397

go back to reference Yamamoto M, Nakagawa M, Ichimura N, Ohtsuki F, Ohtsuka Y, Tsujino Y, Tanaka A, Kamiya T, Wada H (1996) Lymphoblastic transformation of chronic myelomonocytic leukemia in an infant. Am J Hematol 52(3):212–214PubMed Yamamoto M, Nakagawa M, Ichimura N, Ohtsuki F, Ohtsuka Y, Tsujino Y, Tanaka A, Kamiya T, Wada H (1996) Lymphoblastic transformation of chronic myelomonocytic leukemia in an infant. Am J Hematol 52(3):212–214PubMed

go back to reference Bain BJ, Moorman AV, Johansson B, Mehta AB, Secker-Walker LM (1998) Myelodysplastic syndromes associated with 11q23 abnormalities. European 11q23 Workshop participants. Leukemia 12(5):834–839PubMed Bain BJ, Moorman AV, Johansson B, Mehta AB, Secker-Walker LM (1998) Myelodysplastic syndromes associated with 11q23 abnormalities. European 11q23 Workshop participants. Leukemia 12(5):834–839PubMed

go back to reference Nakamura K, Inaba T, Nishimura J, Morgan GJ, Hayashi Y, Hanada R, Yamamoto K, Wada H, Kawaguchi H, Miyashita T, Wiedemann LM, Mizutani S (1991) Molecular analysis of BCR/ABL products in a case of myelodysplastic syndrome with late appearing Philadelphia chromosome. Br J Haematol 78(1):130–132PubMed Nakamura K, Inaba T, Nishimura J, Morgan GJ, Hayashi Y, Hanada R, Yamamoto K, Wada H, Kawaguchi H, Miyashita T, Wiedemann LM, Mizutani S (1991) Molecular analysis of BCR/ABL products in a case of myelodysplastic syndrome with late appearing Philadelphia chromosome. Br J Haematol 78(1):130–132PubMed

go back to reference Rossbach HC, Sutcliffe MJ, Chamizo W, Haag MM, Grana NH, Washington KR, Barbosa JL (1998) Pre-B acute lymphoblastic leukemia in a 3-year-old boy with pre-acute myelogenous leukemia myelodysplastic syndrome: cytogenetic evidence of common early progenitor cell ontogeny. J Pediatr Hematol Oncol 20(4):347–352PubMed Rossbach HC, Sutcliffe MJ, Chamizo W, Haag MM, Grana NH, Washington KR, Barbosa JL (1998) Pre-B acute lymphoblastic leukemia in a 3-year-old boy with pre-acute myelogenous leukemia myelodysplastic syndrome: cytogenetic evidence of common early progenitor cell ontogeny. J Pediatr Hematol Oncol 20(4):347–352PubMed

go back to reference Zainina S, Cheong SK (2006) Myelodysplastic syndrome transformed into acute lymphoblastic leukaemia (FAB:L3). Clin Lab Haematol 28(4):282–283PubMed Zainina S, Cheong SK (2006) Myelodysplastic syndrome transformed into acute lymphoblastic leukaemia (FAB:L3). Clin Lab Haematol 28(4):282–283PubMed

go back to reference Kohno T, Amenomori T, Atogami S, Sasagawa I, Nakamura H, Kuriyama K, Tomonaga M (1996) Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR-ABL transcript. Br J Haematol 93(2):389–391PubMed Kohno T, Amenomori T, Atogami S, Sasagawa I, Nakamura H, Kuriyama K, Tomonaga M (1996) Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR-ABL transcript. Br J Haematol 93(2):389–391PubMed

go back to reference Lima CS, de Souza CA, Cardinalli IA, Lorand-Metze I (1997) Lymphoblastic transformation of myelodysplastic syndrome. Sao Paulo Med J 115(4):1508–1512PubMed Lima CS, de Souza CA, Cardinalli IA, Lorand-Metze I (1997) Lymphoblastic transformation of myelodysplastic syndrome. Sao Paulo Med J 115(4):1508–1512PubMed

go back to reference Disperati P, Ichim CV, Tkachuk D, Chun K, Schuh AC, Wells RA (2006) Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. Leuk Res 30(2):233–239PubMed Disperati P, Ichim CV, Tkachuk D, Chun K, Schuh AC, Wells RA (2006) Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. Leuk Res 30(2):233–239PubMed

go back to reference Sato N, Nakazato T, Kizaki M, Ikeda Y, Okamoto S (2004) Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literature. Int J Hematol 79(2):147–151PubMed Sato N, Nakazato T, Kizaki M, Ikeda Y, Okamoto S (2004) Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literature. Int J Hematol 79(2):147–151PubMed

go back to reference Abruzzese E, Buss D, Rainer R, Pettenati MJ, Rao PN (1996) Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukemia: a case report and cell lineage study. Ann Hematol 73(1):35–38PubMed Abruzzese E, Buss D, Rainer R, Pettenati MJ, Rao PN (1996) Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukemia: a case report and cell lineage study. Ann Hematol 73(1):35–38PubMed

go back to reference Follows GA, Owen RG, Ashcroft AJ, Parapia LA (1999) Eosinophilic myelodysplasia transforming to acute lymphoblastic leukaemia. J Clin Pathol 52(5):388–389PubMedPubMedCentral Follows GA, Owen RG, Ashcroft AJ, Parapia LA (1999) Eosinophilic myelodysplasia transforming to acute lymphoblastic leukaemia. J Clin Pathol 52(5):388–389PubMedPubMedCentral

go back to reference Ikeda T, Sato K, Yamashita T, Kanai Y, Kuwada N, Matsumura T, Nakamura Y, Kimura F, Motoyoshi K (2001) Burkitt's acute lymphoblastic leukaemia transformation after myelodysplastic syndrome. Br J Haematol 115(1):69–71PubMed Ikeda T, Sato K, Yamashita T, Kanai Y, Kuwada N, Matsumura T, Nakamura Y, Kimura F, Motoyoshi K (2001) Burkitt's acute lymphoblastic leukaemia transformation after myelodysplastic syndrome. Br J Haematol 115(1):69–71PubMed

go back to reference Pajor L, Matolcsy A, Vass JA, Méhes G, Marton É, Szabó F, Iványi JL (1998) Phenotypic and genotypic analyses of blastic cell population suggest that pure B-lymphoblastic leukemia may arise from myelodysplastic syndrome. Leuk Res 22(1):13–17PubMed Pajor L, Matolcsy A, Vass JA, Méhes G, Marton É, Szabó F, Iványi JL (1998) Phenotypic and genotypic analyses of blastic cell population suggest that pure B-lymphoblastic leukemia may arise from myelodysplastic syndrome. Leuk Res 22(1):13–17PubMed

go back to reference Kouides PA, Bennett JM (1995) Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol 49(2):157–162PubMed Kouides PA, Bennett JM (1995) Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol 49(2):157–162PubMed

go back to reference Escudier SM, Albitar M, Robertson LE, Andreeff M, Pierce S, Kantarjian HM (1996) Acute lymphoblastic leukemia following preleukemic syndromes in adults. Leukemia 10(3):473–477PubMed Escudier SM, Albitar M, Robertson LE, Andreeff M, Pierce S, Kantarjian HM (1996) Acute lymphoblastic leukemia following preleukemic syndromes in adults. Leukemia 10(3):473–477PubMed

go back to reference Ascensao JL, Kay NE, Wright JJ, Arthur D, Finkel B, Rydell R, Kaplan ME (1986) Lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol 22(4):431–434PubMed Ascensao JL, Kay NE, Wright JJ, Arthur D, Finkel B, Rydell R, Kaplan ME (1986) Lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol 22(4):431–434PubMed

go back to reference Bonati A, Delia D, Starcich R (1986) Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype. Br J Haematol 64(3):487–491PubMed Bonati A, Delia D, Starcich R (1986) Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype. Br J Haematol 64(3):487–491PubMed

go back to reference Inoshita T (1985) Acute lymphoblastic leukemia following myelodysplastic syndrome. Am J Clin Pathol 84(2):233–237PubMed Inoshita T (1985) Acute lymphoblastic leukemia following myelodysplastic syndrome. Am J Clin Pathol 84(2):233–237PubMed

go back to reference Berneman ZN, Van Bockstaele D, De Meyer P et al (1985) A myelodysplastic syndrome preceding acute lymphoblastic leukaemia. Br J Haematol 60(2):353–354PubMed Berneman ZN, Van Bockstaele D, De Meyer P et al (1985) A myelodysplastic syndrome preceding acute lymphoblastic leukaemia. Br J Haematol 60(2):353–354PubMed

go back to reference Pereira AM, Tavares de Castro J, Santos EG, Perloiro MC, Catovsky D (1985) T lymphoblastic transformation of refractory anaemia with excess of blasts. Clin Lab Haematol 7(1):89–95PubMed Pereira AM, Tavares de Castro J, Santos EG, Perloiro MC, Catovsky D (1985) T lymphoblastic transformation of refractory anaemia with excess of blasts. Clin Lab Haematol 7(1):89–95PubMed

go back to reference Hussein KK, Salem Z, Bottomley SS, Livingston RB (1982) Acute leukemia in idiopathic sideroblastic anemia: response to combination chemotherapy. Blood 59(3):652–656PubMed Hussein KK, Salem Z, Bottomley SS, Livingston RB (1982) Acute leukemia in idiopathic sideroblastic anemia: response to combination chemotherapy. Blood 59(3):652–656PubMed

go back to reference Barton JC, Conrad ME, Parmley RT (1980) Acute lymphoblastic leukemia in idiopathic refractory sideroblastic anemia: evidence for a common lymphoid and myeloid progenitor cell. Am J Hematol 9(1):109–115PubMed Barton JC, Conrad ME, Parmley RT (1980) Acute lymphoblastic leukemia in idiopathic refractory sideroblastic anemia: evidence for a common lymphoid and myeloid progenitor cell. Am J Hematol 9(1):109–115PubMed

go back to reference Agostino NM, Ahmed B, Popescu D, Gheith S (2011) Transformation of the 5q- syndrome to acute lymphoblastic leukemia: a report of two cases and review of the literature. Int J Clin Exp Pathol 4(3):322–326PubMedPubMedCentral Agostino NM, Ahmed B, Popescu D, Gheith S (2011) Transformation of the 5q- syndrome to acute lymphoblastic leukemia: a report of two cases and review of the literature. Int J Clin Exp Pathol 4(3):322–326PubMedPubMedCentral

go back to reference Naithani R, Kumar R, Saxena R, Mahapatra M (2009) Transformation of myelodysplastic syndrome to T-cell acute lymphoblastic leukemia in a young adult. Pediatr Hematol Oncol 26(2):100–102PubMed Naithani R, Kumar R, Saxena R, Mahapatra M (2009) Transformation of myelodysplastic syndrome to T-cell acute lymphoblastic leukemia in a young adult. Pediatr Hematol Oncol 26(2):100–102PubMed

go back to reference Algarni AA, Akhtari M, Fu K (2012) Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature. Case Rep Hematol 2012:207537PubMedPubMedCentral Algarni AA, Akhtari M, Fu K (2012) Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature. Case Rep Hematol 2012:207537PubMedPubMedCentral

go back to reference Jain P, Tang G, Konoplev SN, Kanagal-Shamanna R, Wang SA, Pemmaraju N, Daver N, Estrov Z (2016) Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations. Am J Hematol 91(3):354–355PubMedPubMedCentral Jain P, Tang G, Konoplev SN, Kanagal-Shamanna R, Wang SA, Pemmaraju N, Daver N, Estrov Z (2016) Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations. Am J Hematol 91(3):354–355PubMedPubMedCentral

go back to reference Bader-Meunier B, Mielot F, Tchernia G et al (1996) Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. French Society of Paediatric Haematology and Immunology. Br J Haematol 92(2):344–350PubMed Bader-Meunier B, Mielot F, Tchernia G et al (1996) Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. French Society of Paediatric Haematology and Immunology. Br J Haematol 92(2):344–350PubMed

go back to reference Liu D, Chen S, Pan J, Zhu M, Wu N, Zhu F, Chen Z (2012) Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patient. Int J Hematol 96(6):806–809PubMed Liu D, Chen S, Pan J, Zhu M, Wu N, Zhu F, Chen Z (2012) Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patient. Int J Hematol 96(6):806–809PubMed

go back to reference Mishima A, Aoba M, Yamaji S, Taguchi J, Kanamori H, Motomura S, Mohri H, Okubo T (1998) Progression of a myelodysplastic syndrome with trisomy 8 to acute lymphoblastic leukemia. Am J Hematol 58(4):342PubMed Mishima A, Aoba M, Yamaji S, Taguchi J, Kanamori H, Motomura S, Mohri H, Okubo T (1998) Progression of a myelodysplastic syndrome with trisomy 8 to acute lymphoblastic leukemia. Am J Hematol 58(4):342PubMed

go back to reference Nagler A, Brenner B, Tatarsky I (1986) Secondary refractory anemia with excess of blasts in transformation terminating as acute lymphoblastic leukemia. Acta Haematol 76(2–3):164–165PubMed Nagler A, Brenner B, Tatarsky I (1986) Secondary refractory anemia with excess of blasts in transformation terminating as acute lymphoblastic leukemia. Acta Haematol 76(2–3):164–165PubMed

go back to reference Zeidan A, Faltas B, Fricke W, Gore S, Ketterling R, Sham R (2013) Sustained remission in a patient with myelodysplastic syndrome and a complex karyotype after erythropoiesis-stimulating therapy followed by colonic T-cell lymphoblastic lymphoma. Leuk Lymphoma 54(7):1534–1537PubMed Zeidan A, Faltas B, Fricke W, Gore S, Ketterling R, Sham R (2013) Sustained remission in a patient with myelodysplastic syndrome and a complex karyotype after erythropoiesis-stimulating therapy followed by colonic T-cell lymphoblastic lymphoma. Leuk Lymphoma 54(7):1534–1537PubMed

go back to reference Rohr SS, Pelloso LA, Borgo Ados S et al (2012) RARS with fibrosis and del(20q) transformed into ALL. Med Oncol 29(5):3570–3573PubMed Rohr SS, Pelloso LA, Borgo Ados S et al (2012) RARS with fibrosis and del(20q) transformed into ALL. Med Oncol 29(5):3570–3573PubMed

go back to reference Stark AN, Scott CS, Bhatt B, Roberts BE (1986) Myelodysplastic syndrome coexisting with acute lymphoblastic leukaemia. J Clin Pathol 39(7):728–730PubMedPubMedCentral Stark AN, Scott CS, Bhatt B, Roberts BE (1986) Myelodysplastic syndrome coexisting with acute lymphoblastic leukaemia. J Clin Pathol 39(7):728–730PubMedPubMedCentral

go back to reference Serke S, Stein H, Anagnostopoulos I, Schmidt C, Neubauer A, Siegert W, Huhn D (1989) Acute leukaemia with B- and T-lymphoid and myeloid characteristics in a patient with a myelodysplastic syndrome. Br J Haematol 72(1):110–111PubMed Serke S, Stein H, Anagnostopoulos I, Schmidt C, Neubauer A, Siegert W, Huhn D (1989) Acute leukaemia with B- and T-lymphoid and myeloid characteristics in a patient with a myelodysplastic syndrome. Br J Haematol 72(1):110–111PubMed

go back to reference Eridani S, Chan LC, Halil O, Pearson TC (1985) Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome. Br J Haematol 61(3):525–529PubMed Eridani S, Chan LC, Halil O, Pearson TC (1985) Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome. Br J Haematol 61(3):525–529PubMed

go back to reference Serefhanoglu S, Goker H, Buyukasik Y, Sayinalp N, Ozcebe OI (2009) Transformation of adult myelodysplastic syndrome-refractory anemia to acute T-cell lymphoblastic leukemia. J Natl Med Assoc 101(4):370–372PubMed Serefhanoglu S, Goker H, Buyukasik Y, Sayinalp N, Ozcebe OI (2009) Transformation of adult myelodysplastic syndrome-refractory anemia to acute T-cell lymphoblastic leukemia. J Natl Med Assoc 101(4):370–372PubMed

go back to reference Bacher U, Schnittger S, Kern W, Weiss T, Haferlach T, Haferlach C (2009) Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category. Ann Hematol 88(12):1207–1213PubMed Bacher U, Schnittger S, Kern W, Weiss T, Haferlach T, Haferlach C (2009) Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category. Ann Hematol 88(12):1207–1213PubMed

go back to reference Bernasconi P, Klersy C, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, Zappatore R, Caresana M, Dambruoso I, Lazzarino M, Bernasconi C (2007) World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. Br J Haematol 137(3):193–205PubMed Bernasconi P, Klersy C, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, Zappatore R, Caresana M, Dambruoso I, Lazzarino M, Bernasconi C (2007) World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. Br J Haematol 137(3):193–205PubMed

go back to reference Koh YR, Cho EH, Park SS, Park MY, Lee SM, Kim IS, Lee EY (2013) A rare case of transformation of childhood myelodysplastic syndrome to acute lymphoblastic leukemia. Ann Lab Med 33(2):130–135PubMedPubMedCentral Koh YR, Cho EH, Park SS, Park MY, Lee SM, Kim IS, Lee EY (2013) A rare case of transformation of childhood myelodysplastic syndrome to acute lymphoblastic leukemia. Ann Lab Med 33(2):130–135PubMedPubMedCentral